Start for free
Start for free
Cystic Fibrosis Foundation logo

Cystic Fibrosis Foundation

North America, Maryland, United States, Bethesda

Description

Cystic Fibrosis Foundation is the world’s leader in the search for a cure for cystic fibrosis.

Investor Profile

Cystic Fibrosis Foundation has made 17 investments, with 3 in the past 12 months and 18% as lead.

Stage Focus

  • Post Ipo Equity (24%)
  • Series C (18%)
  • Series B (18%)
  • Series A (12%)
  • Series Unknown (12%)
  • Grant (6%)
  • Convertible Note (6%)
  • Undisclosed (6%)

Country Focus

  • United States (53%)
  • Israel (24%)
  • United Kingdom (18%)
  • Canada (6%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Pharmaceutical
  • Genetics
  • Medical
  • Health Diagnostics
  • Life Science
  • Medical Device
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Cystic Fibrosis Foundation frequently co-invest with?

OrbiMed
OrbiMed
North America, New York, United States, New York
Co-Investments: 5
Nantahala Capital Management
Nantahala Capital Management
North America, Connecticut, United States, New Canaan
Co-Investments: 2
Deerfield Management
Deerfield Management
North America, New York, United States, New York
Co-Investments: 2
T. Rowe Price
T. Rowe Price
North America, Maryland, United States, Baltimore
Co-Investments: 3
Atlas Venture
Atlas Venture
North America, Massachusetts, United States, Cambridge
Co-Investments: 2
RA Capital Management
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 2
Longwood Fund
Longwood Fund
North America, Massachusetts, United States, Boston
Co-Investments: 2
Viking Global Investors
Viking Global Investors
North America, Connecticut, United States, Stamford
Co-Investments: 2
Perceptive Advisors
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 2
The Rise Fund
The Rise Fund
North America, California, United States, San Francisco
Co-Investments: 2

What are some of recent deals done by Cystic Fibrosis Foundation?

Owlstone Medical

Cambridge, Cambridgeshire, United Kingdom

Owlstone Medical develops non-invasive breath tests for early disease detection.

Emergency MedicineHealth CareHealth DiagnosticsMedical Device
UndisclosedMar 25, 2025
Amount Raised: $2,300,000
BIOMx

Ness Ziona, HaMerkaz, Israel

BIOMx is a microbiome therapeutics company developing synbio phage therapies to eradicate harmful bacteria in chronic diseases.

BiotechnologyHealth CareTherapeutics
Post Ipo EquityFeb 26, 2025
Amount Raised: $12,000,000
ReCode Therapeutics

Dallas, Texas, United States

ReCode Therapeutics is a genetic medicines company that specializes in mRNA and gene correction therapeutics.

BiopharmaBiotechnologyGeneticsPharmaceuticalTherapeutics
Series UnknownNov 18, 2024
Amount Raised: $15,000,000
Sionna Therapeutics

Natick, Massachusetts, United States

Sionna Therapeutics is developing novel small molecule therapies to treat cystic fibrosis (CF).

BiotechnologyGeneticsHealth CareMedicalPharmaceuticalTherapeutics
Series CMar 6, 2024
Amount Raised: $182,000,000
BIOMx

Ness Ziona, HaMerkaz, Israel

BIOMx is a microbiome therapeutics company developing synbio phage therapies to eradicate harmful bacteria in chronic diseases.

BiotechnologyHealth CareTherapeutics
Post Ipo EquityMar 6, 2024
Amount Raised: $50,000,000
ViaNautis

Cambridge, Cambridgeshire, United Kingdom

ViaNautis is at the forefront of developing novel medications capable of crossing biological barriers.

BiopharmaBiotechnologyMedical
Series ANov 13, 2023
Amount Raised: $24,558,590
BIOMx

Ness Ziona, HaMerkaz, Israel

BIOMx is a microbiome therapeutics company developing synbio phage therapies to eradicate harmful bacteria in chronic diseases.

BiotechnologyHealth CareTherapeutics
Post Ipo EquityFeb 22, 2023
Amount Raised: $7,500,000
Pulmocide

London, England, United Kingdom

Pulmocide is focused on the development of inhaled medicines for the treatment of viral and fungal infections of the respiratory tract.

BiotechnologyHealth CareHealth DiagnosticsMedicalMedical Device
Series CDec 6, 2022
Amount Raised: $52,000,000
Carbon Biosciences

Lexington, Massachusetts, United States

Carbon Biosciences is a biotech company that engages in the novel parvovirus gene therapy.

BiotechnologyProduct ResearchTherapeutics
Series AJun 21, 2022
Amount Raised: $38,000,000
Sionna Therapeutics

Natick, Massachusetts, United States

Sionna Therapeutics is developing novel small molecule therapies to treat cystic fibrosis (CF).

BiotechnologyGeneticsHealth CareMedicalPharmaceuticalTherapeutics
Series BApr 19, 2022
Amount Raised: $110,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator